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It is known that in a part of the population, mainly among children,
some are hypersensitive to soybean protein, although it is not yet
completely elucidated which protein fraction is more immunogenic/
allergenic. The objective of the study was to compare the
immunogenicity and allergenicity of the soy protein fractions. The 2S
(conglycinin), 7S (β conglycinin) and 11S (glycinin) fractions were
isolated from soy protein by affinity chromatography. These purified
soy protein fractions were used as antigens for immunizing BALB/c
mice to evaluate their immunogenicity by following the appearance
of specific IgM and IgG antibodies in blood serum by ELISA. The
allergenicity of these soy protein fractions was evaluated by the
following approaches: i) the production of IgE antibodies against 2S,
7S and 11S soy protein fractions by BALBc mice in the anaphylactic
cutaneous passive test (PCA), and ii) the production of IgG1 specific
antibodies against the 7S fraction in BALB/c mice. The 7S and 11S
fractions induced the formation of IgM and IgG antibodies. The PCA
test showed that only the 7S fraction was allergenic leading to the
production of IgE antibodies. Another evidence that reinforces the
allergenicity of the 7S soy protein fraction is the presence of IgG1
specific antibodies reactive to this protein fraction in immunized mice.
Our study shows that the 7S soy protein fraction is important to elicit
allergic reactions in mice and may contribute to elucidate the
allergenicity of soy-derived products.
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INTRODUCTION
Allergic reactions to foods result from heightened
immunologic responses to glycoprotein components
present in the foods and constitute a frequent health
complaint (Metcalfe, 1991; Shah, Walker, 2002). Children
and adults who develop such reactions are said to have a
food hypersensitivity or food allergy that are terms
proposed to define a reaction to food exposure causing
objectively reproducible symptoms or signs at a dose
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tolerated by normal subjects (Crespo et al., 2004). The
prevalence of food allergy in children appears to be
increasing for reasons that are still poorly understood. It
has been estimated that approximately 6% of young
children and about 2% of the general population have food
allergy, with the majority experiencing gastrointestinal
symptoms (Sampson, 2003).
A number of factors can affect the development of food
allergy. One is the amount of a particular food that is
ingested, which is influenced by diet and culture of a country.
This can have a significant effect on the prevalence of a
specific food allergy in that region. Examples of this are
codfish allergy in Norway, rice and soy allergy in Japan, and
peanut allergy in the U.S. Other factors involved in food
allergies are the gut permeability, that has been considered to
be a major factor in food allergy sensitization, and the food
processing that can substantially modify food allergen
content. Most food allergens are stable molecules that resist
the effect of food processing and cooking and the digestive
processes (Taylor et al., 1987). There are, however,
exceptions such as the labile allergens present in apple and
other fresh fruits and vegetables (Dreborg, Foucart, 1983).
Conversely, it has been suggested that digestion can modify
antigens. Finally, intrinsic factors are present. Most known
food allergens have molecular weights between approxi-
mately 10 and 70 kDa. However, proteins larger than 70 kDa
can also be allergens. by releasing or uncovering new
epitopes, thus increasing allergenicity.
Although several immunologic mechanisms may
operate in allergic reactions to foods, the IgE-mediated
immediate hypersensitivity reaction is, by far, the most well
established mechanism. The IgE-mediated allergic immune
response can be divided into three phases: i) the
sensitization phase in which B cells switch to the
production of specific IgE; ii) the effector phase consisting
of an acute reaction and a facultative late-phase reaction;
iii) a chronic phase that may be the result of repetitive late-
phase reactions (Bischoff et al., 2000). The acute reaction
causes activation of mast cells and basophils releasing
histamine, leukotrienes, and other mediators known to be
responsible for the wheal and flare reaction occurring in the
skin and at various mucosal sites including the eye, nose,
lung, and gastrointestinal tract. This reaction, that occurs
within seconds to minutes, may be followed by a late-phase
reaction starting within 2-24 hours after an allergen
challenge and is characterized by a cellular infiltration of
the tissue with granulocytes (basophils, eosinophils) and
lymphocytes (mainly Th2 cells).
Allergy to proteins of cow milk, eggs, wheat, and soy
is more common in infants and young children, whereas
seafood, peanuts, and tree nuts are the most common cau-
ses of food allergy in adult life (Bischoff et al., 2000).
Once the diagnosis of food hypersensitivity has been
established, the only proven therapy is elimination of the
offending allergen (Sampson, 1983). The first description
of the use of a soy product as a cow milk substitute was
made in 1909 (Ruhrah, 1909). Subsequently, soy protein
formulae have been widely used to feed infants to ensure
not only survival but also a normal life for many children
who were affected by the wide spectrum of clinical
manifestations of cow milk protein allergy (Kay et al.,
1960; Juto et al., 1978; Naidoo et al., 1981; Steichen,
Tsang, 1987; Businco, Cantani, 1990). Surprisingly, a
variety of adverse reactions have been reported involving
soy proteins (Cook, 1960; Sampson, 1991), including
allergenicity of soybean protein fractions (Ratner, 1955;
Shibasaki et al., 1980; Burks et al., 1988; Codina et al.,
2003). The prevalence of a concomitant intolerance to soy
in the allergy to cow milk is between 0% and 63% with high
levels in the enterocolitis/enteropathy syndromes not
associated with IgE (Van Sickle et al., 1985; Bock, Atkins,
1990; Ragno et al., 1993; Burks et al., 1994; Harikul et al.,
1995). However, the true prevalence of allergy to soy
proteins in documented allergies to proteins in cow milk is
not yet well established (Kuitunen et al., 1975; Jakobsson,
Lindberg, 1979; Zeiger et al., 1999; Ahn et al., 2003).
The immunogenicity and allergenicity of soy proteins
is a matter of discussion by several investigators and it is
not completely clear which protein fractions of soy are the
most allergenic. It has been suggested that the 2S and 7S
soy protein fractions are allergenic (Shibasaki et al., 1980;
Ogawa et al., 1991). With the purpose to contribute to the
elucidation of soy allergenicity this study evaluated: i) the
capacity of the 2S, 7S and 11S soy protein fractions to
induce the production of IgM and IgG antibodies in mice;
ii) the induction of the IgE type antibodies by 2S, 7S and
11S soy protein fractions in mice using the PCA test; iii) the




Male BALB/c mice and male Wistar rats, weighing
30-40 g and 150-200 g, respectively, from the “Instituto de
Ciências Biomédicas - Universidade de São Paulo” were
used. All animals had free access to water and food
(commercial chow from Purina®, São Paulo, Brasil). This
experimental study was approved by the Ethics Committee
of Animal Experimentation of the Faculty of Pharmaceutical
Sciences of the University of São Paulo.
Immunogenicity and allergenicity of 2S, 7S and 11S soy protein fractions 599
Isolation of soy protein fractions
The 7S fraction was purified from the soy protein
isolate and the 11S fraction from the defatted soy flour
(Bünge Alimentos, São Paulo, Brazil), according to the
procedures described by Burks et al. (1988) and Thanh,
Shibasaki (1976), respectively, with minor modifications
(Bittencourt et al., 2005). The 7S fraction was extracted
with 20 parts (m/v) of a solution containing 0.03M Tris-
HCl buffer (pH 6.2), 0.001 M dithioerytritol (Sigma Chem.
Co., St Louis, USA), kept under strirring, at 9 ºC for 1 h;
then, the preparation was centrifuged at 35,000 x g at 4 ºC
for 20 min. The pellet was discarded and pH of the
supernatant adjusted to 4.8 with 1N HCl (Merck Co., Rio
de Janeiro, Brazil) and centrifuged at 35,000/g for 20 min,
at 4 ºC. After the elimination of the supernatant, the pellet
was diluted in 10 parts 0.03M Tris-HCl buffer (pH 6.2) and
pH adjusted to 7.6 with 1N NaOH (Merck Co., Rio de
Janeiro, Brazil). This suspension was kept under agitation
at 9 ºC until the pellet dissolved. The pH was adjusted again
to 6.2 and the solution was centrifuged at 35,000 x/g for
20 min, at 4ºC, and supernantant was used as the crude
extract. Then, 0.4 M NaCl (Merck Co., Rio de Janeiro,
Brazil) was added to this extract and the solution was
chromatographed on an affinity column with Concana-
valin-Sepharose 4B (Sigma-Aldrich Ltd., St. Louis, USA).
The second protein peak eluted from this column was
dialyzed against distilled water for 12 h and filtered on
100 kDa membranes. The retained sample in the membrane
was dissolved, concentrated under vacuum and fractionated
by electrophoresis on a 5-20% gradient SDS-PAGE and
followed by Coomassie blue staining. The 2S and 11S
fractions were extracted and purified from the defatted soy
flour that was initially extracted with 20 parts 0.03M Tris-
HCl, pH 8.0, containing 0.01M 2-mercaptoethanol
(Sigma-Aldrich Ltd., St Louis, USA). This sample was
allowed to rest for 1 hour at room temperature and
afterwards was centrifuged at 10,000 rpm for 20 min, at
20 ºC. The first pellet was rejected and the supernatant
considered as the crude extract. The pH was then adjusted
to 6.4 with 2 N HCl and the sample centrifuged at
10,000 rpm for 20 min at 4 ºC. The pH of the supernatant
was adjusted to pH 4.8 and centrifuged again. To eliminate
the possible presence of the soy 2S fraction, whose MW is
identical to the basic subunit of the 11S fraction, the
supernatant was filtered on a 100 kDa membrane (Filtron
Technol. Corp., Northborough, USA) and the retained
sample on the membrane was dissolved and concentrated
under vacuum. The supernatant was analyzed by 5-20%
gradient SDS-PAGE and Coomassie blue staining. The
filtrate was separated on 5-20% gradient SDS-PAGE and
the bands were stained with Coomassie blue for
identification of the 2S soy protein fraction.
Protein Concentration
The total protein concentration in the serum of mice
immunized with 2S, 7S and 11S protein fractions was
evaluated according to Lowry et al. (1951), using bovine
serum albumin as standard.
Immunization
The immunization of BALB/c mice was made in three
steps with different purposes: i) to evaluate the production of
IgM and IgG, groups of 10 BALB/c mice were immunized
with 2S, 7S and 11S protein fractions, separately, in two
steps. Initially these animals received 50 μg of antigen
emulsified in complete Freund’s adjuvant (1:2) administering
200 μL/animal intraperitoneally (i.p). After 15 days, these
animals received 100 μg of the same antigen, emulsified in
incomplete Freund’s adjuvant (1:2) by injecting the same
amount of antigen/animal (i.p.); ii) to evaluate the presence
of IgE, groups of 8 BALB/c mice were immunized with
50 μg of the 2S, 7S and 11S protein fractions, separately,
using 7.5 mg aluminum hydroxide in 0,5 mL saline (i.p.) as
adjuvant, followed by a booster of 5 μg of the same antigen
28 days after the first immunization; iii) to evaluate the
presence of specific IgG1 antibodies, groups of 8 BALB/c
mice were immunized with 50 μg 7S protein fraction
utilizing 7.5 mg of aluminum hydroxide in 0,5 mL saline
(i.p.) as adjuvant, and after 28 days the animals received a
booster of 5 μg of the same antigen. After immunization,
blood was collected periodically in the ophthalmic plexus and
serum (pool) was obtained after centrifugation at 800 g for
10 minutes. Following the collection of blood each animal
was sacrificed with ethyl ether in a closed chamber. These
sera were used to evaluate the production of IgE directed
against the 2S, 7S and 11S protein fractions by using the
PCA test in Wistar rats, as well as the production of IgM, IgG
and IgG1 by ELISA tests.
IgM, and IgG antibodies directed against 2S, 7S and
11S soy protein fractions in mice
Polystyrene plates with 96 wells (EIA/RAI, Costar,
Cambridge, MA, USA) were coated with 50 μL 2S, 7S or
11S fractions (1 μg/well) and incubated for 12 h at 37 ºC.
Excess protein fractions not adsorbed onto plates was
removed by washing with PBS + Tween 20 (0.05% v/v)
followed by blocking with defatted milk at 5% in PBS,
pH 7.2 and incubation for 2 h at 37 ºC. After blockade, plates
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were washed, as described above, and then incubated for 2
h at 37 oC with 50 μL/well of the test serum. The following
steps included washing the plates, addition of 50 μL anti-IgG
(alkaline phosphatase conjugated affinity purified sheep anti-
mouse IgG, Rockland) or anti-IgM (alkaline phosphatase
conjugated affinity purified goat anti-mouse IgM heavy
chain, Rockland) conjugate labeled with alkaline
phosphatase, diluted to 1:1000 in defatted milk at 1% in
PBS, pH 7.2, followed by incubation at 37 ºC for 2 h. After
washing the plates, a solution containing the alkaline
phosphatase substrate (p-nitrophenylphosphate in 0.1 M
glycine, 1 mM MgCl2 and 1 mM ZnCl2, pH 10.4) was added
and left for 30 minutes at room temperature, protected from
light. The reaction was blocked with 50 μL 3 M NaOH and
the absorbance measured at 405 nm. The immunogenicity
was evaluated by measuring the immune humoral response
against the soy protein fractions considering the absorbance
obtained for the different sample dilutions without defining
a threshold for high and low responsiveness
Test of Passive Cutaneous Anaphylaxis
The titers of IgE anaphylactic antibodies in serum from
BALB/c mice were determined using the PCA test. After
immunization of mice with 2S, 7S or 11S protein fractions,
separately, blood was collected weekly through the orbital
plexus and serum was obtained after centrifugation at 800 g
for 10 minutes. The serum obtained from each mouse was kept
at -20 ºC until analysis. The serum pool was prepared from
equal volumes of serum obtained from each mouse at 7, 14, 21,
28 and 35 days after immunization. Wistar rats, shaved on the
back, were sensitized intradermically with 100 μL of a pooled
serum (undiluted, 1/5, 1/10, 1/20, 1/40 and 1/80 serial serum
dilutions) obtained from mice immunized with 2S, 7S or 11S
of soy protein fractions, separately. After 18 and 24 h, the rats
were challenged intravenously (caudal vein) with 1 mL 0.25%
Evans Blue containing 0.5 mg of the same antigen used in the
immunization. At 2 h after challenging, the rats were sacrificed
with ethyl ether in a closed chamber and the reaction was
observed on the inverted skin by measuring the diameter of the
reaction in the skin. The IgE titer was expressed as the
reciprocal of the largest serum dilution which resulted in a
positive reaction in the skin with a diameter ≥ 5 mm. The tests
were made in triplicate considering at least two animals with
positive reactions.
IgG1 antibodies directed against 7S soy protein fraction
in mice
Polystyrene plates with 96 wells (EIA/RAI, Costar,
Cambridge, MA, USA) were coated with 7S soy protein
fraction (10 μg/mL) and incubated overnight. After
incubation the plates were washed with PBS + Tween 20
(0.05% v/v) followed by blocking with defatted milk at 5%
in PBS, pH 7.2 and incubation for 2 h at 37 ºC. The
following steps included washing the plates, addition of
50 μL of test serum and incubation for 2 h at 37 ºC. Then,
the plates were washed and 50 μL LOMG1-PO (peroxidase
conjugated affinity purified rat anti-mouse IgG1) was
added, followed by incubation at 37 ºC for 1h. After
washing the plates, a solution containing 10 μL H2O2 and
10 mg OPD in 10 mL citrate buffer 0.2 M, pH 5.0 was
added and left for 30 minutes at room temperature,
protected from light. The reaction was blocked with 30%
sulfuric acid and the absorbance measured at 490 nm.
RESULTS
Purification of 2S, 7S and 11S protein fractions from
soybean
The analysis by SDS-PAGE in denatured conditions
(50V in the loading phase (7%) and 150V in the separation
phase (20%) confirmed the presence of purified 2S fraction
(MW 20 kDa), α (MW 63.17 kDa), α’ (MW 58.06 kDa)
and β (MW 42.09 kDa) subunits of the 7S fraction and the
acidic (MW 38.8 KDa) and basic (MW 21.04 KDa)
subunits of the 11S fraction of soy (Figure 1).
IgM and IgG antibodies reactive to 2S, 7S and 11S
soy protein fractions produced in mice
The immunogenicity of the 2S, 7S and 11S soy
protein fractions was investigated by evaluating the
FIGURE 1 – SDS-PAGE of 2S soy protein fraction, α, α’
and β subunits of the 7S protein fraction and acidic and
basic subunits of the 11S protein fraction of the soy, stained
with Coomassie blue. Numbers on the left indicate the
migration of molecular weight markers.
Immunogenicity and allergenicity of 2S, 7S and 11S soy protein fractions 601
humoral immune response in mice through the production
of IgM and IgG antibodies. The 2S protein was not
immunogenic in mice as no production of IgM and IgG
antibodies was detected post-immunization of mice with
this soy protein fraction (Figure 2). In contrast, the 7S
fraction induced a strong immune response with a high
production of IgM and IgG, respectively, between the 21st
– 87th and the 21st – 114th days after immunization (Figure
3). The 11S fraction induced an initial and low-intensity
IgM response between the 18th and 43rd days, as well as an
intense IgG production from the 18th to the 90th day after
immunization with two maximal peaks on the 27th and 57th
days (Figure 4).
Evaluation of the 2S, 7S and 11S soy protein fractions
allergenicity by the Passive Cutaneous Anaphylaxis test
(PCA)
The capacity of the 2S, 7S and 11S soy protein
fractions to induce the formation of IgE antibodies in the
immunized BALB/c mice due to the binding capacity of IgE
to mast cells in the skin of rats was investigated by PCA.
The results obtained with the PCA test showed that the 2S
and 11S soy protein fractions did not induce IgE formation
in mice immunized with these proteins. Nevertheless, the
PCA test for the 7S soy protein fraction was positive in the
secondary response (35th day), when an intense production
of IgE due to the 7S booster on the 28th day after the initial
immunization was observed. This positive reaction was
evidenced by a blue stain with a diameter larger than 5 mm
in the rat skin. The diameters of these positive reactions for
undiluted and diluted serum were 16 mm (undiluted) 14 mm
(1/5), 11 mm (1/10), 9 mm (1/20), 8 mm (1/40), 5 mm (1/
80) and 3 mm (1/160), considering 80 as the serum titer,
which corresponded to the inverse of the largest dilution
which resulted in a positive reaction ≥ 5 mm (Figure 5).
Production of specific IgG1 antibodies directed to 7S
soy protein fraction in mice
The presence of specific IgG1 antibodies against the
7S soy protein fraction in BALB/c mice was investigated,
considering that in mice this immunoglobulin isotype, like
FIGURE 3 - Time course of formation of IgM (A) and IgG
(B) antibodies reactive to the 7S soy protein fraction after
immunization of BALB/c mice. The data are expressed as
mean of duplicates.
FIGURE 2 - Time course of production of IgM (A) and IgG
(B) antibodies reactive to the 2S soy protein fraction after
immunization of BALB/c mice. The data are expressed as
mean of duplicates.
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IgE, has the ability to elicit anaphylactic reactions (Ogawa
et al.,  1991). The 7S fraction stimulated the immunological
system of mice to produce IgG1 specific antibodies on days
7, 14, 21 and 28 after immunization with a titer equal to 1/
160. After the 7S soy protein fraction booster received on
day 28 after the initial immunization, the animals presented
a strong immune response with the highest titer equal to 1/
320 on the 35th day after the initial immunization
(secondary response) (Figure 6).
DISCUSSION
The elective treatment for allergy to cow milk protein
is the elimination of this protein from the diet. Prolonged
breast-feeding and the avoidance of cow milk during the
first three months of lactation of high-risk babies decreases
the prevalence and severity of atopic diseases (Businco et
al., 1993). A variety of hypoallergenic formulas have
appeared on the market over the last years for feeding
lactating infants prone to a high atopic risk of allergy to
cow milk. The soy formulas containing sucrose are
particularly indicated in children with protein allergy to
cow milk. On the other hand, the soy proteins may also be
allergenic (Botey et al., 1993; Galli et al., 1996) and there
is a need to define which of the soybean protein fractions is
involved in this allergic process.
To investigate the allergenicity of the soy protein
fractions, animals models are often used considering that
allergic responses upon reexposure to the offending food
reflecting the human situation, has been demonstrated to be
a useful tool to expand the knowledge of mechanisms
FIGURE 5 - Production of IgE antibodies reactive to the 7S
soy protein fraction after immunization of BALB/c mice.
Data are presented as mean ± S.D. and were obtained by the
PCA test at the secondary response (35th day) after a booster
on the 28th day from the initial immunization of BALB/c
mice.
FIGURE 6 - Time course of the production of IgG1
antibodies reactive to the 7S soy protein fraction after
immunization of BALB/c mice. The results were obtained
by ELISA at the secondary response (35th day) after a
booster on the 28th day from the initial immunization of
BALB/c mice. Data are expressed as mean of duplicates. 2ª
– Secondary response on the 35th day of initial immuni-
zation, after booster on the 28th day.
FIGURE 4 -  Time course of formation of IgM (A) and IgG
(B) antibodies reactive to the 11S soy protein fraction after
immunization of BALB/c mice. The data are expressed as
mean of duplicates.
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underlying the development of food allergy and to assess
the potential allergenicity of novel food products. Several
animal models have been developed for research on food
allergy. In the past decade the studies were initiated in small
animal models including guinea pig (Piacentini et al.,
1994), rat (Knippels et al., 1998), and mouse (Li et al.,
2000). Recently, larger animals as dogs (Buchanan and
Frick, 2002) and pigs (Helm et al., 2002), that more closely
mimic human physiology, anatomy, and allergic disease
have been used for food allergy investigation. In relation to
mice, several strains have been used for food allergy
investigation (i.e.: BALB/c, DO11.10, C3H/He, C57BL/
6, CBA, SJL). All these strains show sensitization to
allergens followed by increased formation of IgE and IgG1
antibodies (Wang et al, 1999; Watanabe et al., 2003; Hsieh
et al., 2003; Lifrani et al., 2005), demonstrating that
different mouse strains display similar patterns of allergen-
specific antibody responses.
The presence of IgM and IgG antibodies directed to 7S
and 11S soy protein fractions in mice shown in this study,
reinforces the hypothesis that these fractions are immunogenic
(Figures 3 and 4). These data are in accordance with the study
by Christensen et al. (2003) who analyzed blood from mice fed
a soy-containing diet, by ELISA and immunoblotting, and
showed antibody reactivity towards various soy protein
fractions. They also found antigenic specificity of the serum
antibodies of soy-consuming mice towards both the basic and
the acidic chains of glycinin and the β conglycinin subunits by
immunoblotting.
Other important findings in our study are those
obtained with the PCA test. This test represents an animal
model for inflammatory reactions in type I allergy and has
been a gold standard method to measure allergen-specific
IgE antibody levels in allergy mouse models. The normal
mechanism of the production of IgE antibody starts with the
antigen presentation by antigen presenting cells that can
lead to activation of T cells. These T-helper subsets include
Th1, Th2, Th3 and Tr cell types and through the pattern of
cytokines released, T cells have a different effect on the
differentiation and secretion of antibodies by B cells.
Allergic diseases have been studied in models for Th2 cells
polarization and it is well known that the synthesis of the
human IgE results from interaction between Th2 and B
cells through cytokines, such as, IL-4 and IL-13 and
surface molecules (CD40-CD40L) (Ramos et al., 2003).
The binding of allergens to IgE on mast cells triggers the
release of several mediators, of which histamine is the most
prevalent, regulating several essential events in the immune
response (Mazzoni et al., 2001).
In our experiments with the PCA test, the allergenic
potential of the 7S soy protein fraction was clearly
demonstrated (Figure 5). The positive PCA test for 7S
fraction means that it stimulated the production of IgE
antibodies in mice that sensitized mast cells from the skin
of Wistar rats. The challenge with 7S fraction and Evans
Blue stain in the caudal vein of the rat caused the
degranulation of mast cells that increased the vascular
permeability and caused the overflow of the Evans Blue
stain evidenced by a blue color in the rat skin. Considering
these data it can be suggested that the 7S soy protein
fraction is highly immunogenic and allergenic in mice as it
is capable of triggering degranulation of mast cells through
the production of specific IgE. In contrast, the 2S and 11S
protein fractions did not induce histamine release from mast
cells in this same test. Another important evidence of the 7S
fraction’s allergenicity is the finding of specific IgG1
antibodies in the serum of BALB/c mice which was highly
significant especially after the antigenic booster on the 28th
day of immunization (Figure 6). This finding is extremely
relevant because it has been demonstrated that the
anaphylactic IgG1 enhances the pulmonary eosinophilic
inflammation and airway hyperreactivity (Macedo-Soares
et al., 2004) which reinforce the implication of the 7S
fraction in the allergenicity of soybean.
Considering that the allergenic protein fraction must
be immunogenic, the findings observed here are relevant
and polarize the discussion of the soy protein allergenicity
to the 7S fraction, while our experiments with animals
indicate that the 2S fraction seems not to be implicated in
the allergy to soy proteins. This is in contrast with data
reported by Shibasaki et al. (1980) showing that 2S-
globulin inhibitor could inhibit 90% of the RAST against
2S, 7S and 11S globulins, suggesting that 2S-globulin is the
most potent allergen of the soybean globulins. On the other
hand, Ogawa et al. (1991) suggested that the 7S fraction is
a main allergenic soy protein fraction. In our study with the
2S, 7S and 11S soy protein fractions we used 50 μg of
protein for the initial immunization of mice followed by 5
mg booster of each soy protein fraction for the PCA test.
These differences of experimental protocols could lead to
the different results found in our experiments when
compared with those of Shibasaki et al. (1980).
In conclusion, our study indicated that the 7S soy
protein fraction is allergenic and immunogenic in mice
which can be helpful for those interested in the field of
allergic reactions to soy-derived foodstuffs.
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RESUMO
Imunogenicidade e alergenicidade das frações
protéicas 2S, 7S and 11S da soja
Sabe-se que uma parte da população, principalmente cri-
anças, são hipersensíveis à proteína de soja, embora não
esteja completamente esclarecido qual a fração protéica
mais alergênica. O objetivo do estudo foi comparar a
imunogenicidade e alergenicidade das frações protéicas 2S
(conglicinina), 7S (β conglicinina) e 11S (glicinina) da soja,
isoladas por cromatografia de afinidade. Essas frações
protéicas foram usadas como antígenos para imunizar ca-
mundongos BALB/c e avaliar sua imunogenicidade pela
produção de anticorpos IgM e IgG por ELISA. A
alergenicidade dessas frações foi avaliada de acordo com
os seguintes procedimentos: i) produção de anticorpos IgE
contra as três frações protéicas por camundongos BALBc
pelo teste de anafilaxia cutânea passiva (PCA) e ii) produ-
ção de anticorpos IgG1 contra a fração 7S em camundon-
gos BALB/c por ELISA. As frações 7S e 11S induziram a
formação de anticorpos IgM e IgG. O teste de PCA mostrou
que somente a fração 7S foi alergênica pela produção de
anticorpos IgE. A fração protéica 7S induziu a formação de
anticorpos IgG1 em camundongos imunizados com essa
fração. Nosso estudo mostra que a fração protéica 7S da
soja é importante para desencadear reações alérgicas em
camundongos e pode contribuir para esclarecer a
alergenicidade dos produtos derivados da soja.
UNITERMOS: Alergia alimentar. Soja/ alergenicidade.
Soja/imunogenicidade. ELISA – PCA.
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